Product-level Life Cycle Assessments in the Off-Patent Sector

‘Europe Has To Make Up Its Mind’ – Medicines For Europe’s… 5 August 2025 The president of Medicines for Europe talks about what the…
Patients should benefit from greater access under new patent… 27 April 2023 Open
A streamlined, digital regulatory framework is the… 27 September 2023 The off-patent medicines sector accounts for almost 70% of medicines…
PharmaBoardroom's interview with President Stephan Eder 18 February 2025 President of Medicines for Europe, Stephan Eder, highlights the association's…